含有尿素基因的天然产品及其衍生品的进展:结构和生物活性
Binbin Zhang1, Yating Jia1, Jufen Yan2
1College of Life Sciences, Shanghai Normal University, Shanghai, People's Republic of China.
Chemistry & biodiversity
|August 11, 2025
概括
尿素组增强天然产品,以改善抗癌和抗微生物药物发现. 本次审查强调了它在优化治疗潜力和克服耐药性的作用.
科学领域:
- 药用化学 医学化学
- 自然产品化学 自然产品化学
- 药物发现 药物发现 药物发现
背景情况:
- 尿素组是制药化学中的一个关键支架.
- 它增强生物活动,包括抗癌和抗菌作用.
- 自然产品是治疗剂的丰富来源.
研究的目的:
- 在过去二十年中,审查尿素部分在优化天然产品衍生物中的重要性.
- 要强调尿素功能化在增强治疗潜力的作用.
- 为了指导未来的尿素为中心的药物发现工作.
主要方法:
- 系统审查过去20年发表的研究.
- 评估尿素修饰天然产品的结构-活性关系 (SAR).
- 对乌雷多群体影响的机制性见解的分析.
主要成果:
- 尿素功能化四氨酸类似物对抗多药耐药瘤的抗癌活性有所改善.
- 维布拉斯衍生物具有尿素修饰,表现出增强的蛋白结合和降低毒性.
- 带有尿素调整的Muraymycin类似物显示出对格朗姆阳性病原体的优越抗菌效力.
- 战略性的尿素结合克服了药物动力学挑战,并放大了疗效.
结论:
- 尿素部分是优化基于天然产品的治疗方法的宝贵工具.
- 向性尿素修改为开发针对耐药病原体和瘤的新药提供了一个有希望的战略.
- 本综述为未来的药物发现提供了洞察力,重点是尿素支架.
相关概念视频
Structure-Activity Relationships and Drug Design
1.0K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.0K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.3K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.3K
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
1.2K
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
1.2K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
647
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
647
Preparation of 1° Amines: Hofmann and Curtius Rearrangement Mechanism
3.6K
The Hofmann and Curtius rearrangement reactions can be applied to synthesize primary amines from carboxylic acid derivatives such as amides and acyl azides. In the Hofmann rearrangement, a primary amide undergoes deprotonation in the presence of a base, followed by halogenation to generate an N-haloamide. A second proton abstraction produces a stabilized anionic species, which rearranges to an isocyanate intermediate via an alkyl group migration from the carbonyl carbon to the neighboring...
3.6K
Urea Cycle
45.8K
The urea cycle describes how liver cells convert ammonia to urea. Ammonia is a toxic waste product of protein catabolism. Land animals must convert ammonia into the less toxic urea which can be safely eliminated by the kidneys through urine. Marine animals excrete ammonia directly, and the surrounding water dilutes the ammonia to safe levels.
45.8K


